C12N 5/0678
Stem cells
Official title: {Stem cells; Progenitor cells; Precursor cells}
C12N5/0678 (Stem cells) appears on 204 US grants and 383 published applications in this corpus.
Search patents in C12N- Granted patents
- 204
- Published applications
- 383
- Assignees
- 148
- Inventors
- 431
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 3 |
| 2002 | 1 | 5 |
| 2003 | 1 | 6 |
| 2004 | 2 | 8 |
| 2005 | 3 | 9 |
| 2006 | 2 | 5 |
| 2007 | 3 | 8 |
| 2008 | 4 | 8 |
| 2009 | 4 | 10 |
| 2010 | 2 | 16 |
| 2011 | 2 | 11 |
| 2012 | 6 | 17 |
| 2013 | 5 | 14 |
| 2014 | 6 | 20 |
| 2015 | 17 | 19 |
| 2016 | 14 | 24 |
| 2017 | 14 | 24 |
| 2018 | 11 | 17 |
| 2019 | 20 | 29 |
| 2020 | 7 | 15 |
| 2021 | 14 | 28 |
| 2022 | 16 | 22 |
| 2023 | 5 | 22 |
| 2024 | 17 | 18 |
| 2025 | 13 | 16 |
| 2026 | 6 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Three-dimensional microporous scaffold device for cell culture12 May 2026US 12,623,003 B2The Regents of the University of Michigan
- Methods to induce terminal differentiation in stem cells by interfering with DNA replication, methods of inducing pancreatic differentiation, and differentiated cells obtained thereof21 Apr 2026US 12,605,407 B2The Trustees of Columbia University in the City of New York
- Use of ENTPD3 for identification, isolation, and enhancing mature stem cell derived insulin-producing cells7 Apr 2026US 12,594,306 B2The Regents of the University of Colorado, a body corporate
- Growth inhibitor10 Feb 2026US 12,545,896 B2Orizuru Therapeutics, Inc.
- Method for producing pancreatic β cells13 Jan 2026US 12,522,804 B2Kaneka Corporation
- Compositions and methods for propagating insulin- producing islet cells and therapeutic uses thereof cross reference to related applications8 Oct 2026US 2026/0308530 A1Imagine Pharma LLC
- Cryopreserved endocrine cells that express chromogranin a1 Oct 2026US 2026/0294981 A1ViaCyte, Inc.
- Universal donor cells27 Aug 2026US 2026/0248859 A1Crispr Therapeutics AG
- Methods and materials for generating stem cell-derived endocrine cell types30 Jul 2026US 2026/0218132 A1Mayo Foundation for Medical Education and Research
- In vitro derivation of pancreatic islets from human pluripotent stem cells26 Feb 2026US 2026/0055373 A1Spiber Technologies AB
Most cited
By later US patents
- Human pancreatic epithelial progenitor cells and methods of isolation and use thereof171US 6,436,704 B1Raven Biotechnologies, Inc. · 2002
- In vitro growth of functional islets of Langerhans and in vivo uses thereof169US 6,001,647 AIxion Biotechnology, Inc. · 1999
- Endoderm cells from human embryonic stem cells169US 7,326,572 B2Geron Corporation · 2008
- Tissue matrices comprising placental stem cells, and methods of making the same166US 7,311,904 B2Anthrogenesis Corporation · 2007
- Methods of producing pancreatic hormones165US 7,534,608 B2Cythera, Inc. · 2009